V.

論文業績一覧

V-1.
1.

一元化登録（2009 年 4 月以降）データ利用申請・WG 研究 論文業績

加藤剛二.
小児へのさい帯血移植.

日本さい帯血バンクネットワーク設立 10 周年記念 そして明日から.2009:54-7. 【U1】2.

Mizuta S, Matsuo K, Yagasaki F, Yujiri T, Hatta Y, Kimura Y, Ueda Y, Kanamori H, Usui N, Akiyama H,
Miyazaki Y, Ohtake S, Atsuta Y, Sakamaki H, Kawa K, Morishima Y, Ohnishi K, Naoe T, Ohno R.
Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem celltransplantation for BCR-ABL-positive acute lymphoblastic leukemia.

Leukemia. 2011;25(1):41-7.
3.

【U2】

Takanashi M, Tanaka H, Kohsaki M, Nakajima K, Tadokoro K, Nakabayashi M.
A suggested total size for the cord blood banks of Japan.

Bone Marrow Transplant. 2011;46(7):1014-5.
4.

【U3】

Yagasaki H, Kato M, Ishige M, Shichino H, Chin M, Mugishima H.
Successful cord blood transplantation in a 42-day-old boy with infantile Krabbe disease.

Int J Hematol. 2011;93(4):566-8
5.

【U4】

Ishiyama K, Takami A, Kanda Y, Nakao S, Hidaka M, Maeda T, Naoe T, Taniguchi S, Kawa K, Nagamura
T, Atsuta Y, Sakamaki H.
Allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia with t(6;9)(p23;q34)
dramatically improves the patient prognosis: a matched-pair analysis.

Leukemia. 2012;26(3):461-4.
6.

【U5】

Ishiyama K, Takami A, Kanda Y, Nakao S, Hidaka M, Maeda T, Naoe T, Taniguchi S, Kawa K, Nagamura
T, Tabuchi K, Atsuta Y, Sakamaki H.
Prognostic factors for acute myeloid leukemia patients with t(6;9)(p23;q34) who underwent an allogeneic
hematopoietic stem cell transplant.

Leukemia. 2012;26(6):1416-9.
7.

【U6】

Fuji S, Nakamura F, Hatanaka K, Taniguchi S, Sato M, Mori S, Sakamaki H, Yabe H, Miyamoto T,
Kanamori H, Ueda Y, Kawa K, Kato K, Suzuki R, Atsuta Y, Tamaki T, Kanda Y.
Peripheral blood as a preferable source of stem cells for salvage transplantation in patients with graft
failure after cord blood transplantation: a retrospective analysis of the registry data of the JapaneseSociety for Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2012;18(9):1407-14. 【U7】8.

Kanda J, Hishizawa M, Utsunomiya A, Taniguchi S, Eto T, Moriuchi Y, Tanosaki R, Kawano F, Miyazaki Y,
Masuda M, Nagafuji K, Hara M, Takanashi M, Kai S, Atsuta Y, Suzuki R, Kawase T, Matsuo K,
Nagamura-Inoue T, Kato S, Sakamaki H, Morishima Y, Okamura J, Ichinohe T, Uchiyama T.
Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for
adult T-cell leukemia: a retrospective cohort study.

Blood. 2012;119(9):2141-8. 【U8】

9.

Kanda J, Saji H, Fukuda T, Kobayashi T, Miyamura K, Eto T, Kurokawa M, Kanamori H, Mori T, Hidaka
M, Iwato K, Yoshida T, Sakamaki H, Tanaka J, Kawa K, Morishima Y, Suzuki R, Atsuta Y, Kanda Y.
Related transplantation with HLA-1 Ag mismatch in the GVH direction and HLA-8/8 allele-matchedunrelated transplantation: a nationwide retrospective study.

Blood. 2012;119(10):2409-16. 【U9】10. Kato M, Horikoshi Y, Okamoto Y, Takahashi Y, Hasegawa D, Koh K, Takita J, Inoue M, Kigasawa H,
Ogawa A, Sasahara Y, Kawa K, Yabe H, Sakamaki H, Suzuki R, Kato K.
Second allogeneic hematopoietic SCT for relapsed ALL in children.

Bone Marrow Transplant. 2012;47(10):1307-11. 【WGP 3-1】
11. Kobayashi R, Fujita N, Mitsui T, Iwasaki F, Suzumiya J, Kuroda H, Nishimura R, Sasahara Y, Takeshita Y,
Kato K, Okumura H, Sakamaki H, Yabe H, Kawa K, Kato K, Suzuki R.
Stem cell transplantation for paediatric patients with non-anaplastic peripheral T-cell lymphoma inJapan.

Br J Haematol. 2012;159(1):88-93. 【WGP 9-1】
12. Ishida T, Hishizawa M, Kato K, Tanosaki R, Fukuda T, Taniguchi S, Eto T, Takatsuka Y, Miyazaki Y,
Moriuchi Y, Hidaka M, Akashi K, Uike N, Sakamaki H, Morishima Y, Kato K, Suzuki R, Nishiyama T,
Utsunomiya A.
Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special
emphasis on preconditioning regimen: a nationwide retrospective study.

Blood. 2012;120(8):1734-41. 【WGP 13-1】
13. Hirokawa M, Fukuda T, Ohashi K, Hidaka M, Ichinohe T, Iwato K, Kanamori H, Murata M, Sakura T,
Imamura M, Adachi S, Suzuki R, Morishima Y, Sakamaki H; PRCA Collaborative Study Group.
Efficacy and long-term outcome of treatment for pure red cell aplasia after allogeneic stem celltransplantation from major ABO-incompatible donors.

Biol Blood Marrow Transplant. 2013;19(7):1026-32. 【U10】14. Kurosawa S, Yakushijin K, Yamaguchi T, Atsuta Y, Nagamura-Inoue T, Akiyama H, Taniguchi S,
Miyamura K, Takahashi S, Eto T, Ogawa H, Kurokawa M, Tanaka J, Kawa K, Kato K, Suzuki R,
Morishima Y, Sakamaki H, Fukuda T.
Changes in incidence and causes of non-relapse mortality after allogeneic hematopoietic celltransplantation in patients with acute leukemia/myelodysplastic syndrome: an analysis of the Japan
Transplant Outcome Registry.

Bone Marrow Transplant. 2013;48(4):529-36. 【U11】15. Kurosawa S, Yakushijin K, Yamaguchi T, Atsuta Y, Nagamura-Inoue T, Akiyama H, Taniguchi S,
Miyamura K, Takahashi S, Eto T, Ogawa H, Kurokawa M, Tanaka J, Kawa K, Kato K, Suzuki R,
Morishima Y, Sakamaki H, Fukuda T.
Recent decrease in non-relapse mortality due to GVHD and infection after allogeneic hematopoietic celltransplantation in non-remission acute leukemia.

Bone Marrow Transplant. 2013;48(9):1198-204. 【U12】16. Shinzato A, Tabuchi K, Atsuta Y, Inoue M, Inagaki J, Yabe H, Koh K, Kato K, Ohta H, Kigasawa H, Kitoh
T, Ogawa A, Takahashi Y, Sasahara Y, Kato S, Adachi S.
PBSCT is associated with poorer survival and increased chronic GvHD than BMT in Japanese paediatricpatients with acute leukaemia and an HLA-matched sibling donor.

Pediatr Blood Cancer. 2013;60(9):1513-9. 【U13】17. Imahashi N, Suzuki R, Fukuda T, Kakihana K, Kanamori H, Eto T, Mori T, Kobayashi N, Iwato K, Sakura
T, Ikegame K, Kurokawa M, Kondo T, Iida H, Sakamaki H, Tanaka J, Kawa K, Morishima Y, Atsuta Y,
Miyamura K.
Allogeneic hematopoietic stem cell transplantation for intermediate cytogenetic risk AML in first CR.

Bone Marrow Transplant. 2013;48(1):56-62. 【U14】18. Sawada A, Ohga S, Ishii E, Inoue M, Okada K, Inagaki J, Goto H, Suzuki N, Koike K, Atsuta Y, Suzuki R,
Yabe H, Kawa K, Kato K, Yasutomo K.
Feasibility of reduced-intensity conditioning followed by unrelated cord blood transplantation for primary
hemophagocytic lymphohistiocytosis: a nationwide retrospective analysis in Japan.

Int J Hematol. 2013;98(2):223-30. 【U15】19. 永澤雅秀.
移植に必要な AB 型の血漿・血小板製剤の需給動向について.

血液事業.2013;35(4):703-5. 【U16】20. Chihara D, Ito H, Matsuda T, Katanoda K, Shibata A, Taniguchi S, Utsunomiya A, Sobue T, Matsuo K.
Association between decreasing trend in the mortality of adult T-cell leukemia/lymphoma and allogeneic
hematopoietic stem cell transplants in Japan: analysis of Japanese vital statistics and Japan Society for
Hematopoietic Cell Transplantation (JSHCT).

Blood Cancer J. 2013;3:e159. 【U17】21. Kato M, Takahashi Y, Tomizawa D, Okamoto Y, Inagaki J, Koh K, Ogawa A, Okada K, Cho Y, Takita J,
Goto H, Sakamaki H, Yabe H, Kawa K, Suzuki R, Kudo K, Kato K.
Comparison of intravenous with oral busulfan in allogeneic hematopoietic stem cell transplantation withmyeloablative conditioning regimens for pediatric acute leukemia.

Biol Blood Marrow Transplant. 2013;19(12):1690-4. 【WGP 3-2】
22. Kanamori H, Mizuta S, Kako S, Kato H, Nishiwaki S, Imai K, Shigematsu A, Nakamae H, Tanaka M,
Ikegame K, Yujiri T, Fukuda T, Minagawa K, Eto T, Nagamura-Inoue T, Morishima Y, Suzuki R, Sakamaki
H, Tanaka J.
Reduced-intensity allogeneic stem cell transplantation for patients aged 50 years or older with B-cell ALL
in remission: a retrospective study by the Adult ALL Working Group of the Japan Society for
Hematopoietic Cell Transplantation.

Bone Marrow Transplant. 2013;48(12):1513-8. 【WGP 4-1】

23. Nishiwaki S, Miyamura K, Ohashi K, Kurokawa M, Taniguchi S, Fukuda T, Ikegame K, Takahashi S, Mori
T, Imai K, Iida H, Hidaka M, Sakamaki H, Morishima Y, Kato K, Suzuki R, Tanaka J; Adult Acute
Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.
Impact of a donor source on adult Philadelphia chromosome-negative acute lymphoblastic leukemia: aretrospective analysis from the Adult Acute Lymphoblastic Leukemia Working Group of the Japan Societyfor Hematopoietic Cell Transplantation.

Ann Oncol. 2013;24(6):1594-602. 【WGP 4-2】
24. Tanaka J, Kanamori H, Nishiwaki S, Ohashi K, Taniguchi S, Eto T, Nakamae H, Minagawa K, Miyamura
K, Sakamaki H, Morishima Y, Kato K, Suzuki R, Nishimoto N, Oba K, Masauzi N.
Reduced-intensity vs myeloablative conditioning allogeneic hematopoietic SCT for patients aged over 45
years with ALL in remission: a study from the Adult ALL Working Group of the Japan Society for
Hematopoietic Cell Transplantation (JSHCT).

Bone Marrow Transplant. 2013;48(11):1389-94. 【WGP 4-3】
25. Kikuchi A, Yabe H, Kato K, Koh K, Inagaki J, Sasahara Y, Suzuki R, Yoshida N, Kudo K, Kobayashi R,
Tabuchi K, Kawa K, Kojima S.
Long-term outcome of childhood aplastic anemia patients who underwent allogeneic hematopoietic SCT
from an HLA-matched sibling donor in Japan.

Bone Marrow Transplant. 2013;48(5):657-60. 【WGP 11-1】
26. Ishida T, Hishizawa M, Kato K, Tanosaki R, Fukuda T, Takatsuka Y, Eto T, Miyazaki Y, Hidaka M, Uike N,
Miyamoto T, Tsudo M, Sakamaki H, Morishima Y, Suzuki R, Utsunomiya A.
Impact of Graft-versus-Host Disease on Allogeneic Hematopoietic Cell Transplantation for Adult T Cell
Leukemia-Lymphoma Focusing on Preconditioning Regimens: Nationwide Retrospective Study.

Biol Blood Marrow Transplant. 2013;19(12):1731-9. 【WGP 13-2】
27. Kanda Y, Kanda J, Atsuta Y, Maeda Y, Ichinohe T, Ohashi K, Fukuda T, Miyamura K, Iida H, Mori T,
Iwato K, Eto T, Kawa K, Morita S, Morishima Y.
Impact of a single human leucocyte antigen (HLA) allele mismatch on the outcome of unrelated bonemarrow transplantation over two time periods. A retrospective analysis of 3003 patients from the HLAWorking Group of the Japan Society for Blood and Marrow Transplantation.

Br J Haematol. 2013;161(4):566-77. 【WGP 17-1】
28. Tanaka J, Morishima Y, Takahashi Y, Yabe T, Oba K, Takahashi S, Taniguchi S, Ogawa H, Onishi Y,
Miyamura K, Kanamori H, Aotsuka N, Kato K, Kato S, Atsuta Y, Kanda Y.
Effects of KIR ligand incompatibility on clinical outcomes of umbilical cord blood transplantation without
ATG for acute leukemia in complete remission.

Blood Cancer J. 2013;3:e164. 【WGP 17-2】
29. Atsuta Y, Kanda J, Takanashi M, Morishima Y, Taniguchi S, Takahashi S, Ogawa H, Ohashi K, Ohno Y,
Onishi Y, Aotsuka N, Nagamura-Inoue T, Kato K, Kanda Y; HLA Working Group of the Japan Society for
Hematopoietic Cell Transplantation.
Different effects of HLA disparity on transplant outcomes after single-unit cord blood transplantation
between pediatric and adult patients with leukemia.

Haematologica. 2013;98(5):814-22. 【WGP 17-3】

30. Kanda J, Atsuta Y, Wake A, Ichinohe T, Takanashi M, Morishima Y, Taniguchi S, Takahashi S, Ogawa H,
Ohashi K, Ohno Y, Aotsuka N, Onishi Y, Kato K, Nagamura-Inoue T, Kanda Y; HLA Working Group of theJapan Society for Hematopoietic Cell Transplantation.
Impact of the direction of HLA mismatch on transplantation outcomes in single unrelated cord bloodtransplantation.

Biol Blood Marrow Transplant. 2013;19(2):247-54.

【WGP 17-4】

31. Kanda J, Ichinohe T, Kato S, Uchida N, Terakura S, Fukuda T, Hidaka M, Ueda Y, Kondo T, Taniguchi S,
Takahashi S, Nagamura-Inoue T, Tanaka J, Atsuta Y, Miyamura K, Kanda Y; Donor/Source Working
Group and HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.
Unrelated cord blood transplantation vs related transplantation with HLA 1-antigen mismatch in thegraft-versus-host direction.

Leukemia. 2013;27(2):286-94.

【WGP 18-1】

32. Murata M, Nakasone H, Kanda J, Nakane T, Furukawa T, Fukuda T, Mori T, Taniguchi S, Eto T, Ohashi K,
Hino M, Inoue M, Ogawa H, Atsuta Y, Nagamura-Inoue T, Yabe H, Morishima Y, Sakamaki H, Suzuki R.
Clinical factors predicting the response of acute graft-versus-host disease to corticosteroid therapy: ananalysis from the GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2013;19(8):1183-9. 【WGP 19-1】
33. Nakasone H, Kanda J, Yano S, Atsuta Y, Ago H, Fukuda T, Kakihana K, Adachi T, Yujiri T, Taniguchi S,
Taguchi J, Morishima Y, Nagamura T, Sakamaki H, Mori T, Murata M; GVHD Working Group of theJapan Society for Hematopoietic Cell Transplantation.
A case-control study of bronchiolitis obliterans syndrome following allogeneic hematopoietic stem celltransplantation.

Transpl Int. 2013;26(6):631-9. 【WGP 19-2】
34. Nakasone H, Kurosawa S, Yakushijin K, Taniguchi S, Murata M, Ikegame K, Kobayashi T, Eto T,
Miyamura K, Sakamaki H, Morishima Y, Nagamura T, Suzuki R, Fukuda T.
Impact of hepatitis C virus infection on clinical outcome in recipients after allogeneic hematopoietic celltransplantation.

Am J Hematol. 2013;88(6):477-84. 【WGP 20-1】
35. Nakasone H, Onizuka M, Suzuki N, Fujii N, Taniguchi S, Kakihana K, Ogawa H, Miyamura K, Eto T,
Sakamaki H, Yabe H, Morishima Y, Kato K, Suzuki R, Fukuda T.
Pre-transplant risk factors for cryptogenic organizing pneumonia/bronchiolitis obliterans organizing
pneumonia after hematopoietic cell transplantation.

Bone Marrow Transplant. 2013;48(10):1317-23. 【WGP 20-2】
36. Kato M, Matsumoto K, Suzuki R, Yabe H, Inoue M, Kigasawa H, Inagaki J, Koh K, Hashii Y, Tauchi H,
Suminoe A, Kikuta A, Sakamaki H, Kawa K, Kato K, Fukuda T.
Salvage allogeneic hematopoietic SCT for primary graft failure in children.

Bone Marrow Transplant. 2013;48(9):1173-8. 【WGP 20-3】

37. Konuma T, Ooi J, Uchida N, Ogawa H, Ohashi K, Kanamori H, Aotsuka N, Onishi Y, Yamaguchi H, Kozai
Y, Nagamura-Inoue T, Kato K, Suzuki R, Atsuta Y, Kato S, Asano S, Takahashi S.
Granulocyte colony-stimulating factor combined regimen in cord blood transplantation for acute myeloid
leukemia: a nationwide retrospective analysis in Japan.

Haematologica. 2014;99(12):e264-8. 【U18】38. Iida M, Fukuda T, Uchida N, Murata M, Aotsuka N, Minagawa K, Oohashi K, Fukushima K, Kondo T, Eto
T, Miyamoto T, Morishima Y, Nagamura T, Atsuta Y, Suzuki R.
Mycophenolate mofetil use after unrelated hematopoietic stem cell transplantation for prophylaxis andtreatment of graft-vs.-host disease in adult patients in Japan.

Clin Transplant. 2014;28(9):980-9. 【U19】39. Murata M, Nishida T, Taniguchi S, Ohashi K, Ogawa H, Fukuda T, Mori T, Kobayashi H, Nakaseko C,
Yamagata N, Morishima Y, Nagamura-Inoue T, Sakamaki H, Atsuta Y, Suzuki R, Naoe T.
Allogeneic transplantation for primary myelofibrosis with BM, peripheral blood or umbilical cord blood: ananalysis of the JSHCT.

Bone Marrow Transplant. 2014;49(3):355-60. 【U20】40. Muramatsu H, Sakaguchi H, Taga T, Tabuchi K, Adachi S, Inoue M, Kitoh T, Suminoe A, Yabe H, Azuma E,
Shioda Y, Ogawa A, Kinoshita A, Kigasawa H, Osugi Y, Koike K, Kawa K, Kato K, Atsuta Y, Kudo K.
Reduced intensity conditioning in allogeneic stem cell transplantation for AML with Down syndrome.

Pediatr Blood Cancer. 2014;61(5):925-7. 【WGP 1-1】
41. Takami A, Yano S, Yokoyama H, Kuwatsuka Y, Yamaguchi T, Kanda Y, Morishima Y, Fukuda T, Miyazaki
Y, Nakamae H, Tanaka J, Atsuta Y, Kanamori H.
Donor lymphocyte infusion for the treatment of relapsed acute myeloid leukemia after allogeneic
hematopoietic stem cell transplantation: a retrospective analysis by the Adult Acute Myeloid Leukemia
Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2014;20(11):1785-90. 【WGP 2-1】
42. Aoki J, Ishiyama K, Taniguchi S, Fukuda T, Ohashi K, Ogawa H, Kanamori H, Eto T, Iwato K, Sakamaki
H, Morishima Y, Nagamura T, Atsuta Y, Takami A.
Outcome of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia patients withcentral nervous system involvement.

Biol Blood Marrow Transplant. 2014;20(12):2029-33. 【WGP 2-2】
43. Kato H, Kawase T, Kako S, Mizuta S, Kurokawa M, Mori T, Ohashi K, Iwato K, Miyamura K, Hidaka M,
Sakamaki H, Suzuki R, Morishima Y, Tanaka J.
Analysis of outcomes following autologous stem-cell transplantation in adult patients with Philadelphia
chromosome-negative acute lymphoblastic leukemia during the first complete remission.

Haematologica. 2014;99(11):e228-30. 【WGP 4-4】
44. Mizuta S, Matsuo K, Nishiwaki S, Imai K, Kanamori H, Ohashi K, Fukuda T, Onishi Y, Miyamura K,Takahashi S, Onizuka M, Atsuta Y, Suzuki R, Morishima Y, Kato K, Sakamaki H, Tanaka J.
Pretransplant administration of imatinib for allo-HSCT in patients with BCR-ABL-positive acutelymphoblastic leukemia.

Blood. 2014;123(15):2325-32. 【WGP 4-5】

45. Ohashi K, Nagamura-Inoue T, Nagamura F, Tojo A, Miyamura K, Mori T, Kurokawa M, Taniguchi S,
Ishikawa J, Morishima Y, Atsuta Y, Sakamaki H.
Effect of graft sources on allogeneic hematopoietic stem cell transplantation outcome in adults withchronic myeloid leukemia in the era of tyrosine kinase inhibitors: a Japanese Society of Hematopoietic Cell
Transplantation retrospective analysis.

Int J Hematol. 2014;100(3):296-306. 【WGP 6-1】
46. Kato M, Yoshida N, Inagaki J, Maeba H, Kudo K, Cho Y, Kurosawa H, Okimoto Y, Tauchi H, Yabe H,
Sawada A, Kato K, Atsuta Y, Watanabe K.
Salvage allogeneic stem cell transplantation in patients with pediatric myelodysplastic syndrome andmyeloproliferative neoplasms.

Pediatr Blood Cancer. 2014; 61 (10): 1860-6. 【WGP 7-1】
47. Chihara D, Izutsu K, Kondo E, Sakai R, Mizuta S, Yokoyama K, Kaneko H, Kato K, Hasegawa Y, Chou T,
Sugahara H, Henzan H, Sakamaki H, Suzuki R, Suzumiya J.
High-dose chemotherapy with autologous stem cell transplantation for elderly patients withrelapsed/refractory diffuse large B-cell lymphoma: a nationwide retrospective study.

Biol Blood Marrow Transplant. 2014 ;20(5):684-9. 【WGP 10-1】
48. Yoshida N, Kobayashi R, Yabe H, Kosaka Y, Yagasaki H, Watanabe K, Kudo K, Morimoto A, Ohga S,
Muramatsu H, Takahashi Y, Kato K, Suzuki R, Ohara A, Kojima S.
Firstline treatment for severe aplastic anemia in children: bone marrow transplantation from a matchedfamily donor versus immunosuppressive therapy.

Haematologica. 2014;99(12):1784-91. 【WGP 11-2】
49. Kobayashi R, Yabe H, Kikuchi A, Kudo K, Yoshida N, Watanabe K, Muramatsu H, Takahashi Y, Inoue M,
Koh K, Inagaki J, Okamoto Y, Sakamaki H, Kawa K, Kato K, Suzuki R, Kojima S.
Bloodstream infection after stem cell transplantation in children with idiopathic aplastic anemia.

Biol Blood Marrow Transplant. 2014;20(8):1145-9. 【WGP 11-3】
50. Kato K, Choi I, Wake A, Uike N, Taniguchi S, Moriuchi Y, Miyazaki Y, Nakamae H, Oku E, Murata M, Eto
T, Akashi K, Sakamaki H, Kato K, Suzuki R, Yamanaka T, Utsunomiya A.
Treatment of patients with adult T cell leukemia/lymphoma with cord blood transplantation: a Japanesenationwide retrospective survey.

Biol Blood Marrow Transplant. 2014;20(12):1968-74. 【WGP 13-3】
51. Kanda Y, Kanda J, Atsuta Y, Fuji S, Maeda Y, Ichinohe T, Takanashi M, Ohashi K, Fukuda T, Miyamura K,
Mori T, Sao H, Kobayashi N, Iwato K, Sawada A, Mori S; HLA working group of the Japan Society for
Hematopoietic Cell Transplantation.
Changes in the clinical impact of high-risk human leukocyte antigen allele mismatch combinations on theoutcome of unrelated bone marrow transplantation.

Biol Blood Marrow Transplant. 2014;20(4):526-35. 【WGP 17-5】

52. Kanda J, Fuji S, Kato S, Takami A, Tanaka J, Miyamura K, Ohashi K, Fukuda T, Ozawa Y, Kanamori H,
Eto T, Kobayashi N, Iwato K, Morishima Y, Sakamaki H, Atsuta Y, Kanda Y; HLA Working Group;
Donor/Source Working Group; Adult AML Working Group; Adult ALL Working Group of the Japan Societyfor Hematopoietic Cell Transplantation.
Decision analysis for donor selection in stem cell transplantation-HLA-8/8 allele-matched unrelated donor
vs HLA-1 AG mismatched related donor.

Blood Cancer J. 2014;4:e263. 【WGP 17-6】
53. Fuji S, Kanda J, Kato S, Ikegame K, Morishima S, Miyamoto T, Hidaka M, Kubo K, Miyamura K, Ohashi
K, Kobayashi H, Maesako Y, Adachi S, Ichinohe T, Atsuta Y, Kanda Y; HLA Working Group of Japan
Society for Hematopoietic Cell Transplantation.
Impact of HLA allele mismatch on the clinical outcome in serologically matched related hematopoietic
SCT.

Bone Marrow Transplant. 2014;49(9):1187-92. 【WGP 17-7】
54. Kuwatsuka Y, Atsuta Y, Horowitz MM, Inagaki J, Kanda J, Kato K, Koh K, Zhang MJ, Eapen M; Center
for International Blood and Marrow Transplant Research (CIBMTR), and Donor/Source and GVHDWorking Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT).
Graft-versus-host disease and survival after cord blood transplantation for acute leukemia: a comparisonof Japanese versus White populations.

Biol Blood Marrow Transplant. 2014;20(5):662-7. 【WGP 18-2】
55. Kanda J, Nakasone H, Atsuta Y, Toubai T, Yokoyama H, Fukuda T, Taniguchi S, Ohashi K, Ogawa H, Eto T,
Miyamura K, Morishima Y, Nagamura-Inoue T, Sakamaki H, Murata M.
Risk factors and organ involvement of chronic GVHD in Japan.

Bone Marrow Transplant. 2014;49(2):228-35. 【WGP 19-3】
56. Fuji S, Takano K, Mori T, Eto T, Taniguchi S, Ohashi K, Sakamaki H, Morishima Y, Kato K, Miyamura K,
Suzuki R, Fukuda T.
Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCT.

Bone Marrow Transplant. 2014;49(12):1505-12. 【WGP 20-4】
57. Ishida H, Adachi S, Hasegawa D, Okamoto Y, Goto H, Inagaki J, Inoue M, Koh K, Yabe H, Kawa K, Kato K,
Atsuta Y, Kudo K.
Comparison of a fludarabine and melphalan combination-based reduced toxicity conditioning withmyeloablative conditioning by radiation and/or busulfan in acute myeloid leukemia in Japanese children
and adolescents.

Pediatr Blood Cancer. (in press). 【WGP 1-2】
58. Kato K, Kato M, Hasegawa D, Kawasaki H, Ishida H, Okamoto Y, Koh K, Inoue M, Inagaki J, Kato,
Sakamaki H, Yabe H, Kawa K, Suzuki R, and Atsuta Y.
Comparison of transplantation with reduced and myeloablative conditioning for children with acutelymphoblastic leukemia.

Blood. 2015;125(8):1352-4. 【WGP 3-3】

59. Goto H, Kaneko T, Shioda Y, Kajiwara M, Sakashita K, Kitoh T, Hayakawa A, Miki M, Kato K, Ogawa A,
Hashii Y, Inukai T, Kato C, Sakamaki H, Yabe H, Suzuki R, Kato K.
Hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia and Down
syndrome.

Pediatr Blood Cancer. 2015;62(1):148-52. 【WGP 3-4】
60. Kato M, Hasegawa D, Koh K, Kato K, Takita J, Inagaki J, Yabe H, Goto H, Adachi S, Hayakawa A,
Takeshita Y, Sawada A, Atsuta Y, Kato K.
Allogeneic haematopoietic stem cell transplantation for infant acute lymphoblastic leukaemia withKMT2A (MLL) rearrangements: a retrospective study from the paediatric acute lymphoblastic leukaemia
working group of the Japan Society for Haematopoietic Cell Transplantation.

Br J Haematol. 2015;168(4):564-70. 【WGP 3-5】
61. Aoki K , Ishikawa T, Ishiyama K, Aoki J, Itonaga H, Fukuda T, Kakihana K, Uchida N, Ueda Y, Eto T,
Mori T, Kondo T, Iwato K, Morishima Y, Tanaka J, Atsuta Y, Miyazaki Y; Adult Myelodysplastic
Syndromes Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT).
Allogeneic haematopoietic cell transplantation with reducedintensity conditioning for elderly patientswith advanced myelodysplastic syndromes: a nationwide study.

Br J Haematol. 2015;168(3):463-6. 【WGP 8-1】
62. Fukano R, Mori T, Kobayashi R, Mitsui T, Fujita N, Iwasaki F, Suzumiya J, Chin M, Goto H, Takahashi Y,
Hara J, Park YD, Inoue M, Koga Y, Inagaki J, Sakamaki H, Adachi S, Kawa K, Kato K, Suzuki R.
Haematopoietic stem cell transplantation for relapsed or refractory anaplastic large cell lymphoma: astudy of children and adolescents in Japan.

Br J Haematol. (in press). 【WGP 9-2】
63. Kako S, Izutsu K, Kato K, Kim SW, Mori T, Fukuda T, Kobayashi N, Taji H, Hashimoto H, Kondo T,
Sakamaki H, Morishima Y, Kato K, Suzuki R, Suzumiya J; Adult Lymphoma Working Group of theJapanese Society for Hematopoietic Cell Transplantation.
The role of hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma.

Am J Hematol. 2015;90(2):132-8. 【WGP 10-2】
64. Takamatsu H, Honda S, Miyamoto T, Yokoyama K, Hagiwara S, Ito T, Tomita N, Iida S, Iwasaki T,
Sakamaki H, Suzuki R, Sunami K.
Changing trends in prognostic factors for patients with multiple myeloma after autologous stem celltransplantation during the immunomodulator drug/proteasome inhibitor era.

Cancer Sci. (in press). 【WGP 14-1】
65. Kawamura K, Takamatsu H, Ikeda T, Komatsu T, Aotsuka N, Amano I, Yamamoto G, Watanabe K, Ohno Y,
Matsue K, Kouzai Y, Tsukada N, Ishiyama K, Anzai N, Kato K, Suzuki R, Sunami K, Kanda Y.
Cord blood transplantation for multiple myeloma: study from the Multiple Myeloma Working Group of theJapan Society for Hematopoietic Cell Transplantation.

Biology of Blood and Marrow Transplant. (in press).

【WGP 14-2】

66. Kanda J, Ichinohe T, Fuji S, Maeda Y, Ohashi K, Fukuda T, Miyamura K, Iwato K, Eto T, Nakamae H,
Kobayashi N, Mori T, Mori S, Morishima Y, Atsuta Y, Kanda Y; HLA Working Group of the Japan Societyfor Hematopoietic Cell Transplantation.
Impact of HLA Mismatch Direction on the Outcome of Unrelated Bone Marrow Transplantation: A
Retrospective Analysis from the Japan Society for Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2015;21(2):305-11. 【WGP 17-8】
67. Tanaka M, Miyamura K, Terakura S, Imai K, Uchida N, Ago H, Sakura T, Eto T, Ohashi K, Fukuda T,
Taniguchi S, Mori S, Nagamura-Inoue T, Atsuta Y, Okamoto S.
Comparison of Cord Blood Transplantation with Unrelated Bone Marrow Transplantation in Patients
Older than Fifty Years.

Biol Blood Marrow Transplant. 2015;21(3):517-25. 【WGP 18-3】
68. Nakasone H, Fukuda T, Kanda J, Mori T, Yano S, Kobayashi T, Miyamura K, Eto T, Kanamori H, Iwato K,
Uchida N, Mori S, Nagamura-Inoue T, Ichinohe T, Atsuta Y, Teshima T, Murata M.
Impact of conditioning intensity and TBI on acute GVHD afterhematopoietic cell transplantation.

Bone Marrow Transplant. (in press). 【WGP 19-4】
69. Nakane T, Fukuda T, Kanda J, Taniguchi S, Eto T, Ohashi K, Nakamae H, Kurokawa M, Mori T,
Morishima Y, Nagamura-Inoue T, Sakamaki H, Atsuta Y, Murata M.
Age influences post-graft-versus-host disease non-relapse mortality in adults with acute graft-versus-hostdisease of varying severity following allogeneic hematopoietic cell transplant.

Leuk Lymphoma. (in press).

【WGP 19-5】

70. Umeda K, Adachi S, Tanaka S, Ogawa A, Hatakeyama N, Kudo K, Sakata N, Igarashi S, Ohshima K,
Hyakuna N, Chin M, Goto H, Takahashi Y, Azuma E, Koh K, Sawada A, Kato K, Inoue M, Atsuta Y,
Takami A, Murata M; on behalf of the GVHD Working Group of the Japan Society for Hematopoietic Cell
Transplantation.
Comparison of continuous and twice-daily infusions of cyclosporine A for graft-versus-host-disease
prophylaxis in pediatric hematopoietic stem cell transplantation.

Pediatr Blood Cancer. (in press). 【WGP 19-6】
71. Takano K, Fuji S, Uchida N, Ogawa H, Ohashi K, Eto T, Sakamaki H, Morishima Y, Kato K, Suzuki R,
Fukuda T.
Pre-transplant diabetes mellitus is a risk factor for non-relapse mortality, especially infection-related
mortality, after allogeneic hematopoietic SCT.

Bone Marrow Transplant. (in press). 【WGP 20-5】